Sunmoon is incorporated in 1992. In a span of little more than a decade gained reputation for adopting the latest manufacturing technologies, providing world class quality products, ground breaking Research & Development efforts and for setting new standards in customer service. Sunmoon outstands to be strategic resource for its customers. Sunmoon always aims to reach the best results at competitive costs.
Sunmoon business model integrates CRAMS, Drug discovery, Clinical trials, Bulk drug manufacturing, Finished dosage manufacturing. A complete solution for Cancer Care.
We also undertake research in the identification, validation and development of cancer biomarkers and their integration with clinical drug development and molecular diagnostics.
Sunmoon today has a national and global footprint . Sunmoon is having Exclusive supply agreement for cancer drugs with HCG , a largest cancer chain of hospitals in S E Asia. Sunmoon is present in several countries in the continents of Asia, Europe, Africa & America.
Sunmoon offers one of the broadest product portfolios and strongest pipelines in the oncology generics industry with around 30 products on the market at present and about 15 products are under development and pending registration. Sunmoon’s products are under registration in many countries.
The success of Sunmoon is founded on meeting the expectation of all our customers, our people and the communities in which we live.